|
Volumn 2, Issue , 1997, Pages
|
Chemotherapy of advanced ovarian cancer.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
PACLITAXEL;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
MAXIMUM TOLERATED DOSE;
OVARY TUMOR;
PATHOLOGY;
PROGNOSIS;
RETROSPECTIVE STUDY;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CISPLATIN;
CLINICAL TRIALS;
FEMALE;
HUMANS;
MAXIMUM TOLERATED DOSE;
OVARIAN NEOPLASMS;
PACLITAXEL;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 4243405487
PISSN: None
EISSN: 10934715
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|